Covis Secures Agreement with Glaxo

By Angela Sormani — 4 years ago

Covis Pharma Sàrl, a Switzerland- based specialty pharmaceutical company owned by affiliates of Cerberus Capital Management has reached an agreement with GlaxoSmithKline to acquire full commercial rights for some of its products in the US and Puerto Rico. Covis Pharma is also backed by Princeton Biopharma Capital Partners and Bourne Capital Partners. PRESS RELEASE Align […]